An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with Human Immunodeficiency Virus.

CONCLUSIONS: Relative to patients initiating a new INSTI, patients initiating a new PI were less likely to experience ≥5% weight/BMI gain post-index. Additionally, mean weight/BMI gain was lower in the PI than in the INSTI cohort. PMID: 32459155 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research